Harrow Health, Inc.

Historical 13F Holders

Symbol
HROW
CUSIP
415858109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 415858109 since 12/18/2024, largest first.

Filer % of Class Filed
Mark L. Baum 13D/A 10.7% 4/7/2025
Event 4/3/2025
Opaleye Management Inc. 13G/A
6.4% 7/31/2026
Event 6/30/2026
Kaufman Daniel Louis 13G 5.0% 3/11/2026
Event 3/10/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 18 149 k $4.59 M
2026 Q2 236 23.1 M $951 M
2026 Q1 231 21.5 M $757 M
2025 Q4 230 22.3 M $1.09 B
2025 Q3 212 21.3 M $1.03 B
2025 Q2 170 21.3 M $650 M
2025 Q1 170 21.1 M $561 M
2024 Q4 182 20.9 M $701 M
2024 Q3 176 21.2 M $954 M
2024 Q2 122 19.3 M $403 M
2024 Q1 124 22.8 M $301 M
2023 Q4 123 24.5 M $275 M
2023 Q3 136 25.1 M $361 M
2023 Q2 117 23.0 M $438 M
2023 Q1 120 20.9 M $443 M
2022 Q4 102 18.2 M $268 M
2022 Q3 86 15.3 M $185 M
2022 Q2 92 16.2 M $147 M
2022 Q1 85 15.4 M $115 M
2021 Q4 84 15.5 M $145 M
2021 Q3 84 14.6 M $145 M
2021 Q2 97 13.7 M $139 M
2021 Q1 99 15.0 M $101 M
2020 Q4 87 13.0 M $88.9 M
2020 Q3 79 11.8 M $65.9 M
2020 Q2 75 11.0 M $57.1 M
2020 Q1 65 7.47 M $28.5 M
2019 Q4 70 7.63 M $59.4 M
2019 Q3 62 7.39 M $41.5 M
2019 Q2 62 6.47 M $56.1 M
2019 Q1 56 6.36 M $31.7 M
2018 Q4 4 487 k $2.77 M